Advertisement
Advertisement
U.S. markets close in 2 hours 32 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Theravance Biopharma, Inc. (TBPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
9.99+0.15 (+1.52%)
As of 01:23PM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/24/2022
Current
6/30/20223/31/202212/31/20219/30/20216/30/2021
Market Cap (intraday)
667.16M692.43M727.33M822.51M545.37M1.07B
Enterprise Value
1.21B1.22B1.22B1.28B948.73M1.53B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/A7.657.789.13N/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
14.2612.0512.0112.517.4213.94
Price/Book (mrq)
N/AN/AN/AN/AN/AN/A
Enterprise Value/Revenue
23.14110.2192.7185.4871.91118.41
Enterprise Value/EBITDA
-26.65206.80-102.74-70.45-45.62-39.62

Trading Information

Stock Price History

Beta (5Y Monthly) 0.66
52-Week Change 332.97%
S&P500 52-Week Change 3-16.03%
52 Week High 313.17
52 Week Low 37.18
50-Day Moving Average 39.37
200-Day Moving Average 39.53

Share Statistics

Avg Vol (3 month) 3966.08k
Avg Vol (10 day) 3860.83k
Shares Outstanding 566.78M
Implied Shares Outstanding 6N/A
Float 835.12M
% Held by Insiders 19.85%
% Held by Institutions 186.89%
Shares Short (Aug 30, 2022) 47.73M
Short Ratio (Aug 30, 2022) 415.18
Short % of Float (Aug 30, 2022) 415.57%
Short % of Shares Outstanding (Aug 30, 2022) 410.12%
Shares Short (prior month Jul 28, 2022) 47.47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin -193.71%
Operating Margin (ttm)-265.43%

Management Effectiveness

Return on Assets (ttm)-22.00%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)52.39M
Revenue Per Share (ttm)0.70
Quarterly Revenue Growth (yoy)-14.40%
Gross Profit (ttm)-138.35M
EBITDA -133.71M
Net Income Avi to Common (ttm)-101.48M
Diluted EPS (ttm)-2.02
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)132.85M
Total Cash Per Share (mrq)1.74
Total Debt (mrq)677.96M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.74
Book Value Per Share (mrq)-4.58

Cash Flow Statement

Operating Cash Flow (ttm)-128.68M
Levered Free Cash Flow (ttm)-36.66M
Advertisement
Advertisement